pyrrolidonecarboxylic acid has been researched along with Pancreatic Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, B; Guan, X; Hao, C; Liu, D; Tian, X; Wang, W; Wu, J; Yan, L; Zhao, M | 1 |
| Hijikata, T; Ichikawa, H; Morimoto, Y; Takahashi, T; Tsuneyama, K | 1 |
| Akinsanya, KO; Bennet, WM; Bloom, SR; Byfield, PG; Ghatei, MA; Kulkarni, RN; Smith, DM; Wang, RM; Wang, ZL | 1 |
| Lapis, K; Schally, AV; Szepeshazi, K | 1 |
4 other study(ies) available for pyrrolidonecarboxylic acid and Pancreatic Neoplasms
| Article | Year |
|---|---|
Identification of the γ-glutamyl cycle as a novel therapeutic target and 5-oxoproline as a new biomarker for diagnosing pancreatic cancer.
Topics: Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Humans; Pancreatic Neoplasms; Pyrrolidonecarboxylic Acid; Tumor Microenvironment | 2023 |
Inhibition of EP2/EP4 prostanoid receptor-mediated signaling suppresses IGF-1-induced proliferation of pancreatic cancer BxPC-3 cells via upregulating γ-glutamyl cyclotransferase expression.
Topics: Cell Line, Tumor; Cell Proliferation; gamma-Aminobutyric Acid; gamma-Glutamylcyclotransferase; Humans; Insulin-Like Growth Factor I; Isoindoles; Metabolome; Pancreatic Neoplasms; Pyrrolidonecarboxylic Acid; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP4 Subtype; Signal Transduction; Sulfonamides; Up-Regulation; Xanthones | 2019 |
Pyroglutamyl-phenylalanyl-proline amide attenuates thyrotropin-releasing hormone-stimulated insulin secretion in perifused rat islets and insulin-secreting clonal beta-cell lines.
Topics: Amino Acid Sequence; Animals; Cricetinae; Glucose; Humans; Inositol Phosphates; Insulin; Insulin Secretion; Insulinoma; Islets of Langerhans; Kinetics; Male; Molecular Sequence Data; Oligopeptides; Pancreatic Neoplasms; Perfusion; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Thyrotropin-Releasing Hormone; Tumor Cells, Cultured | 1995 |
Effect of combination treatment with analogs of luteinizing hormone-releasing hormone (LH-RH) or somatostatin and 5-fluorouracil on pancreatic cancer in hamsters.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinogens; Cricetinae; Drug Screening Assays, Antitumor; Female; Fluorouracil; Gonadotropin-Releasing Hormone; Mesocricetus; Nitrosamines; Organ Size; Pancreatic Neoplasms; Pyrrolidonecarboxylic Acid; Somatostatin | 1991 |